The PAX1/JAM3 methylation panel could serve as a triage tool for CC among women undergoing evaluation for cervical disease, particularly in postmenopausal patients and may enhance colposcopy by providing more accurate lesion diagnosis. Here, JAM3 is linked to cervicitis.